The Daily Differential — Thursday, July 30, 2026

Pulmonary HTN and Sleep Apnea

Obstructive sleep apnea can produce chronic hypoxemia, sympathetic surges, and pulmonary vascular remodeling, but acute dyspnea may instead reflect pulmonary embolism, left-heart failure, or decompensated pulmonary arterial hypertension. Missing right-ventricular failure can make routine diuresis, intubation, or hypotension lethal.

By the Blue Fish Med Desk Jul 30, 2026 · Phoenix

0:00 / –:–– AI‑generated audio

A 58-year-old man arrives after nearly falling asleep at a red light, his collar damp with sweat and his wife’s portable pulse oximeter blinking 86%. He has gained 20 pounds over the past year and wakes most nights “fighting for air,” but says he has no chest pain. In the room, he speaks in short sentences after walking from the waiting area, and his ankles leave deep marks in his socks. The question is whether this is a chronic nighttime breathing problem—or a dangerous cardiopulmonary decompensation unfolding now.

— What’s your move? Read on.

Before you read

When does hypoxemia require escalation beyond simple oxygen?
What emergency diagnoses must be excluded before attributing dyspnea to sleep apnea?

When to Think of It

Think of the OSA–pulmonary hypertension link in patients with loud snoring, witnessed apneas, morning headaches, resistant hypertension, obesity, daytime sleepiness, unexplained hypoxemia, exertional presyncope, loud P2, RV heave, edema, or elevated JVP. OSA alone usually causes mild pulmonary-pressure elevation; severe pulmonary hypertension should prompt a search for additional causes.

Sick or Not Sick

Sick: hypoxemia despite oxygen, syncope, hypotension, altered mental status, severe RV dysfunction, rising lactate, chest pain, or rapidly worsening dyspnea. The key call is whether this is acute right-ventricular failure or another immediately reversible cardiopulmonary process, not simply “sleep apnea.”

The First Fifteen Minutes

Sit upright, monitor continuously, obtain IV access, ECG, glucose, blood gas, CBC/CMP, troponin, BNP, and bedside ultrasound.
Hypoxemia → nasal cannula 2–6 L/min, titrating generally to SpO₂ 92–96%; in chronic hypercapnic respiratory failure, target 88–92%. Oxygen reverses hypoxic pulmonary vasoconstriction.
Persistent obstructive events or hypercapnia with preserved airway reflexes → CPAP 5–10 cm H₂O or BiPAP starting 10/5 cm H₂O, titrated to work of breathing and gas exchange; positive pressure splints the airway but excessive mean pressure can reduce RV preload.
Hypotension from RV failure → norepinephrine 0.05–0.1 mcg/kg/min IV infusion, titrated, because systemic pressure preserves RV coronary perfusion; use a pump and check local protocol.
Pulmonary hypertensive crisis with severe hypoxemia/RV failure and specialist or ICU support → inhaled epoprostenol commonly 10–50 ng/kg/min or inhaled nitric oxide 10–20 ppm; dosing varies substantially, so verify institutional/ICU protocol.
If pulmonary embolism is strongly suspected and bleeding risk is acceptable → unfractionated heparin 80 units/kg IV bolus, then 18 units/kg/hour infusion, because it prevents clot propagation while definitive testing/procedure is arranged.

Definitive Care & Disposition

Treat the driver: formal sleep testing, CPAP adherence, weight management, and evaluation for obesity hypoventilation. Obtain echocardiography; confirm and classify pulmonary hypertension with right-heart catheterization after stabilization. Admit patients with syncope, hypoxemia, RV dysfunction, rising biomarkers, or escalating support; ICU for shock, severe respiratory failure, or pulmonary hypertensive crisis. Do not begin chronic pulmonary vasodilators empirically in undifferentiated pulmonary hypertension.

How This One Kills

The dangerous miss is intubating a preload-dependent, severely hypertensive RV without preparation: induction-related vasodilation and positive-pressure ventilation can abruptly eliminate RV output and cause peri-intubation arrest.

The Differential — What Else Looks Like This

Pulmonary embolism — abrupt dyspnea, pleuritic pain, or unexplained tachycardia; mislabeling it as OSA delays anticoagulation or reperfusion.
Left-sided heart failure — pulmonary edema, orthopnea, S3, and diffuse B-lines; treating isolated “RV failure” without addressing LV disease worsens congestion.
Obesity hypoventilation syndrome — awake hypercapnia (PaCO₂ >45 mm Hg) in obesity; missing it leads to oxygen-only treatment and worsening CO₂ retention.
COPD/asthma — wheeze and obstructive spirometry; confusing it with pulmonary vascular disease delays bronchodilator therapy and appropriate testing.

The Second-Day Story

Older adults may present with fatigue, falls, nocturia, depression, or resistant hypertension rather than “sleepiness.” Patients with chronic hypoxemia may have normal daytime oxygen saturation while developing exertional desaturation and subtle RV failure. Ask the bed partner about witnessed apneas, inspect neck veins and edema, check exertional saturation, and use bedside echo for RV enlargement or septal flattening rather than relying on symptoms alone.

Back to Our Patient

Back to the 58-year-old man with the damp collar and blinking oximeter: he is recognized as having severe sleep-disordered breathing symptoms, but exertional desaturation, edema, and short sentences make simple OSA insufficient as the working diagnosis. His blood pressure is 92/60, lactate is elevated, bedside echo shows a dilated hypokinetic RV with septal flattening, and CT angiography demonstrates no PE; this is decompensated pulmonary hypertension with RV failure, so he receives controlled oxygen and noninvasive support, with norepinephrine triggered by persistent hypotension and urgent ICU/pulmonary consultation. He is admitted to the ICU for hemodynamic support, echocardiography, and later sleep testing and pulmonary-hypertension classification.

Patient Presentation to Attending

How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling

“This is a 58-year-old man with obesity and witnessed nocturnal apneas presenting with progressive exertional dyspnea, daytime somnolence, and new bilateral leg edema. He has gained 20 pounds, wakes gasping, and has no fever, hemoptysis, or chest pain, but is hypoxemic at 86% after walking and now speaks in short sentences. He is hypotensive at 92/60 with elevated JVP, a loud P2, peripheral edema, and no focal wheeze or unilateral leg findings. Lactate is elevated, troponin is mildly positive, and bedside echo shows a dilated, poorly contracting RV with septal flattening; CT angiography shows no PE. My assessment is acute decompensated pulmonary hypertension with RV failure, likely worsened by untreated sleep-disordered breathing. I would provide controlled oxygen and noninvasive ventilatory support, start norepinephrine for persistent hypotension, involve pulmonary/critical care, and admit him to the ICU.”

Study Directive

Draw the pathway from obstructive apnea → intermittent hypoxemia/sympathetic activation → pulmonary vasoconstriction → RV strain from memory.
Practice a 60-second bedside distinction between OSA, obesity hypoventilation, PE, and acute heart failure.
Review CPAP/BiPAP contraindications and perform five focused RV ultrasound examinations.
Memorize the heparin and norepinephrine starting doses; verify inhaled pulmonary vasodilator dosing in your ICU protocol.

4 of 4

Pneumocystis jirovecii

Pneumocystis jirovecii pneumonia (PJP) causes subacute hypoxemic respiratory failure, especially in advanced HIV or other cellular-immunodeficiency states....

0:00 / –:–– AI‑generated audio

The Case

A 39-year-old man sits forward beneath a blanket, breathing quickly enough that his phone slips from his hand. He has lost 15 pounds, reports three weeks of dry cough and fevers, and becomes markedly short of breath walking to the bathroom; the pulse oximeter reads 88% while he speaks. His chest radiograph shows only faint bilateral haze despite the severity of his breathing. The team must determine whether this is an opportunistic infection—and whether oxygen alone is enough while the diagnosis is confirmed.

Before You Read

Which clinical and gas-exchange findings should trigger empiric therapy?
When do adjunctive corticosteroids improve outcome?
Why can a relatively unimpressive chest radiograph be misleading?

Why It Matters

Pneumocystis jirovecii pneumonia (PJP) causes subacute hypoxemic respiratory failure, especially in advanced HIV or other cellular-immunodeficiency states. Delayed treatment and failure to recognize exertional or occult hypoxemia are common causes of deterioration.

When to Think of It

Think PJP with 1–8 weeks of progressive dyspnea, fever, nonproductive cough, fatigue, weight loss, hypoxemia, and diffuse bilateral ground-glass or interstitial changes—particularly with HIV, CD4 <200, transplant, hematologic malignancy, prolonged corticosteroids, or immunomodulator use. LDH may be elevated but is nonspecific. A normal chest radiograph does not exclude early disease.

Sick or Not Sick

Sick: resting SpO₂ <92%, marked exertional desaturation, respiratory distress, PaO₂ <70 mm Hg, A–a gradient ≥35 mm Hg, hemodynamic instability, or inability to protect the airway. The key call is whether the patient has moderate-to-severe hypoxemia requiring adjunctive steroids and admission.

The First Fifteen Minutes

Place on continuous pulse oximetry, obtain IV access, CBC/CMP, ABG or VBG with clinical correlation, lactate if ill, HIV testing when appropriate, blood cultures if septic, and chest imaging.
Hypoxemia → oxygen by nasal cannula, titrated to SpO₂ 92–96%; oxygen corrects impaired diffusion and V/Q mismatch.
Significant work of breathing or escalating oxygen need → high-flow nasal cannula; consider noninvasive ventilation if appropriate, while preparing early ICU involvement.
Strong clinical suspicion with hypoxemia or high-risk immunosuppression → TMP-SMX at 15–20 mg/kg/day of the trimethoprim component, divided IV or PO every 6–8 hours, because it inhibits folate metabolism in Pneumocystis; dose and renal adjustment require checking Lexicomp, UpToDate, or institutional protocol.
Moderate-to-severe PJP (PaO₂ <70 mm Hg on room air or A–a gradient ≥35) → prednisone 40 mg PO twice daily for days 1–5, 40 mg daily days 6–10, then 20 mg daily days 11–21; IV methylprednisolone at 75–80% of the prednisone dose may be used if unable to take PO. Start within 72 hours because it blunts inflammatory deterioration.
If severe hypoxemia cannot be controlled with conventional oxygen → escalate respiratory support and ICU care; do not delay antimicrobial therapy for bronchoscopy.

Definitive Care & Disposition

Confirm with induced sputum or bronchoscopy/BAL PCR, direct fluorescent staining, or organism-specific testing; PCR can detect colonization, so interpret with clinical and radiographic findings. Treat for 21 days in HIV-associated PJP; non-HIV duration and regimen should follow specialist/institutional guidance. Evaluate for HIV, CD4 count, viral load, medication adherence, and other opportunistic infections. Admit all hypoxemic patients; ICU for high-flow/NIV, severe work of breathing, shock, or impending intubation. Begin or optimize antiretroviral therapy with infectious-disease input, commonly within 2 weeks of starting PJP therapy in newly diagnosed HIV.

How This One Kills

The lethal miss is treating “mild” radiographic disease while ignoring exertional or resting hypoxemia; PJP can progress rapidly to diffuse alveolar injury and respiratory failure.

The Atypical Presentation

In patients receiving corticosteroids or with profound immunosuppression, fever may be absent and the cough may be minimal. Chest radiography can be normal early, while exertional desaturation is striking. Measure oxygenation at rest and with brief monitored ambulation when safe, and maintain suspicion even when auscultation is quiet.

Back to Our Patient

Back to the 39-year-old man under the blanket: subacute dry cough, weight loss, immunocompromise, exertional dyspnea, and resting SpO₂ 88% make PJP the leading diagnosis despite only faint radiographic haze. He is placed on oxygen, receives empiric TMP-SMX after bloodwork and HIV testing, and meets criteria for adjunctive prednisone because his ABG shows a PaO₂ of 62 mm Hg on room air. Bronchoscopy is deferred until he is stabilized; he is admitted to a monitored bed with early ICU consultation, and later BAL PCR and staining confirm PJP.

Patient Presentation to Attending

“This is a 39-year-old man with three weeks of progressive dyspnea, dry cough, fevers, and 15-pound weight loss, with previously undiagnosed HIV risk factors. He is tachypneic and hypoxemic at 88% on room air, with clear-to-faint bilateral breath sounds and no focal consolidation, edema, or purulent sputum. Chest radiograph shows subtle bilateral interstitial haze, and ABG reveals a PaO₂ of 62. My assessment is moderate-to-severe PJP causing hypoxemic respiratory failure. I am starting oxygen, empiric TMP-SMX, and adjunctive prednisone, sending HIV and microbiologic testing, and admitting him with close respiratory monitoring and ICU escalation if oxygen needs increase.”

Study Directive

Memorize the TMP-SMX dose based on the trimethoprim component, not the combined tablet weight.
Practice calculating the A–a gradient in three hypoxemic cases and identify the steroid threshold.
Review PJP diagnostic tests, their limitations, and indications for induced sputum versus BAL.
Build a one-page differential for subacute dyspnea in advanced HIV, including PJP, TB, CMV, bacterial pneumonia, Kaposi sarcoma, and pulmonary embolism.

Key Medications

TMP-SMX: 15–20 mg/kg/day TMP component IV or PO divided every 6–8 hours for treatment; verify renal adjustment, formulation, and local protocol.
Prednisone: 40 mg PO twice daily days 1–5, 40 mg daily days 6–10, then 20 mg daily days 11–21 for moderate/severe HIV-associated PJP.
Methylprednisolone: approximately 75–80% of the prednisone dose IV when enteral therapy is not possible; confirm institutional conversion protocol.
Alternative regimens such as IV pentamidine 4 mg/kg/day or clindamycin plus primaquine require specialist guidance and additional toxicity screening; dosing variability is meaningful.
Pediatric PJP dosing is weight-based and differs from adult regimens; consult a pediatric infectious-disease reference.

High-Yield Pearls

Exertional desaturation may be the earliest objective abnormality; check it when safe.
Elevated LDH supports but does not diagnose PJP; organism detection must be interpreted in clinical context because PCR may reflect colonization.
A normal or subtly abnormal radiograph cannot overrule severe hypoxemia in an immunocompromised patient.

The Mimics

Bacterial pneumonia — focal infiltrate, purulent sputum, abrupt fever; confusing it delays TMP-SMX and steroid therapy.
Viral pneumonia/COVID-19 — similar ground-glass changes; coinfection is possible, so a positive viral test does not exclude PJP.
Tuberculosis — constitutional symptoms and immunosuppression; missing TB risks airborne transmission and inappropriate monotherapy.
Pulmonary edema — orthopnea, edema, elevated JVP, and B-lines; diuresis alone fails if PJP is driving hypoxemia.

Board Question

A patient with newly diagnosed HIV has suspected PJP. PaO₂ is 62 mm Hg on room air. Which additional therapy is indicated?

APrednisone adjunctive therapy
BInhaled corticosteroid alone
CRoutine prophylactic antibiotics only
DImmediate antiretroviral therapy before antimicrobial treatment

Reveal answer

Correct: A

Prednisone adjunctive therapy. PaO₂ <70 mm Hg or an A–a gradient ≥35 mm Hg indicates moderate-to-severe PJP, for which corticosteroids reduce inflammatory worsening when started promptly. Antimicrobial therapy should not be delayed; ART is generally initiated during treatment with specialist guidance.

Recent Literature

Review or guideline Pneumocystis jirovecii pneumonia in people living with HIV: a review
Clin Microbiol Rev, 2024 · cited 49×

A current, comprehensive reference for recognizing, diagnosing, and treating PJP in patients with HIV, including initial antimicrobial and adjunctive corticosteroid decisions.

Full text · open access
Recent clinical Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial
Lancet Respir Med, 2025 · cited 31×

Provides randomized trial evidence to guide the previously uncertain use of adjunctive corticosteroids in non-HIV immunocompromised patients presenting with severe PJP.

Full text · open access

TheDaily Differential

Pulmonary HTN and Sleep Apnea

When to Think of It

Sick or Not Sick

The First Fifteen Minutes

Definitive Care & Disposition

How This One Kills

The Second-Day Story

Study Directive

More in Today's Issue

Pulmonary Hypertension

Hydrocarbons and Inhaled Agents Toxicity and Poisoning

Pneumocystis jirovecii

Yesterday’s Differential

Journal Watch

The 18 Best Computed Tomography Training Courses

Blunt cerebrovascular injury

Podcast Picks

Heat Stroke and Other Heat-Related Illness

The Case of the Malignant Cohort

Critical Care Corner

Obstructive Sleep Apnoea

Pharmacology Corner

Cefepime

Clevidipine

ECG of the Day

Case of the Day